Global Respiratory Syncytial Virus-Related Infant Community Deaths

Natalie I Mazur1, Yvette N Löwensteyn1, Joukje E Willemsen1

  • 1Division of Infectious Diseases, Department of Pediatrics, University Medical Centre Utrecht, Utrecht, The Netherlands.

Insights

Infants in low-income countries are dying from respiratory syncytial virus (RSV) at younger ages in the community. This highlights the potential impact of maternal RSV vaccination for community mortality prevention.

Area of Science:

  • Global Health
  • Pediatric Infectious Diseases
  • Epidemiology

Background:

  • Respiratory syncytial virus (RSV) is a major cause of pediatric mortality, predominantly in low- and lower-middle-income countries.
  • Over half of RSV-related deaths occur in the community, yet these cases are poorly characterized.

Purpose of the Study:

  • To compare the age distribution of infant deaths (<6 months) from RSV occurring in the community versus in-hospital settings.
  • To assess the potential impact of future RSV interventions on community mortality.

Main Methods:

  • Analysis of 829 RSV-related deaths in infants (<1 year) from 38 developing countries via the RSV Global Online Mortality Database (RSV GOLD).
  • Specific focus on 166 community deaths from 12 countries and 629 deaths <6 months of age.
  • Comparison of median age at death and proportion of neonatal deaths between community and in-hospital settings.

Main Results:

  • Infants dying from RSV in the community were younger (median 1.5 months) than those dying in-hospital (median 2.4 months).
  • A higher proportion of neonatal deaths occurred in the community (29%) compared to in-hospital (12%).

Conclusions:

  • Community-based RSV deaths in infants occur at a younger age.
  • Maternal vaccination or immunoprophylaxis strategies are anticipated to significantly reduce community-based RSV mortality.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
449
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
428
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
239
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
401
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
288